Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | CCR3 | P51677 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8069502 | 0.97 | RAB9A (0.50) | RAB9ANPC1CCR3EPHX1MEN1 | |
| SCHEMBL4542461 | 0.97 | RAB9A (0.50) | RAB9ANPC1CCR3EPHX1MEN1 | |
| SCHEMBL4539998 | 0.90 | LMNA (0.55) | EPHX1EPHX2 | |
| SCHEMBL4542837 | 0.90 | RAB9A (0.53) | RAB9AEPHX1EPHX2 | |
| SCHEMBL4535376 | 0.90 | BRD4 (0.54) | EPHX1EPHX2 | |
| SCHEMBL4537185 | 0.88 | RAB9A (0.56) | RAB9ANPC1EPHX1EPHX2 | |
| SCHEMBL4537316 | 0.87 | LMNA (0.56) | RAB9AEPHX1EPHX2 | |
| SCHEMBL4542345 | 0.87 | EPHX2 (0.56) | RAB9AEPHX1EPHX2 | |
| SCHEMBL4537833 | 0.86 | RAB9A (0.48) | RAB9ANPC1SMN1; SMN2MAPTTDP1 | |
| SCHEMBL4536842 | 0.86 | RAB9A (0.50) | RAB9ANPC1SMN1; SMN2MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009070497-A1 | SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE | SMITHKLINE BEECHAM CORPORATION (US) | 2009-06-04 | — | — | WO | claimed |
| WO-2009070497-A1 | SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE | SMITHKLINE BEECHAM CORPORATION (US) | 2009-06-04 | — | — | WO | disclosed |